BigHat Biosciences, Inc.
Machine learning and synthetic biology platform for designing safer, more effective antibody therapies
- Sector
- Biotech
- Headquarters
- SAN MATEO, CA
- Founded
- 2019
- Latest Form D
- $80M, Oct 2022
- Total capital
- $104M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $104M
- 3 Form D · last Oct 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 16 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$80M
- Private capital raisedForm D · SEC · 2nd filing$18.8M
- Private capital raisedForm D · SEC · 1st filing$5.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Francisco GimenezDirectorNamed in SEC Form D filings
- Mark DePristoExecutive Officer, DirectorNamed in SEC Form D filings
- Peyton GreensideExecutive Officer, DirectorNamed in SEC Form D filings
- Robert ChessDirectorNamed in SEC Form D filings
- Steve KafkaDirectorNamed in SEC Form D filings
- Theresa TribblePromoterNamed in SEC Form D filings
Show all 7 people
- Vineeta AgarwalaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 16- PendingANTI-CDH17 Antibodies And Use Of The SameUSPTOApplication 19151550
- PendingPh-selective ANTI-CD3 Antibodies And Use Of The SameUSPTOApplication 18869653
- PendingSARS-COV(-2) Spike Glycoprotein-binding Domains And Polypeptides Comprising The Same And Use Of The SameUSPTOApplication 18119183
Show all 16 patent records
- ANTI-CDH17 Antibodies And Use Of The SameJun 18, 2026 · Application 19151550Pending
- Ph-selective ANTI-CD3 Antibodies And Use Of The SameOct 9, 2025 · Application 18869653Pending
- SARS-COV(-2) Spike Glycoprotein-binding Domains And Polypeptides Comprising The Same And Use Of The SameFeb 22, 2024 · Application 18119183Pending
- ANTI-CDH17 Antibodies And Use Of The SameApplication PCTUS2024013798Pending
- P- And E-selectin-binding Compositions And Methods Of Use ThereofApplication 63528316Pending
- Ph-selective ANTI-CD3 Antibodies And Use Of The SameApplication PCTUS2023067579Pending
- Ph-selective ANTI-CD3 Antibodies And Use Of The SameApplication 63496657Pending
- ANTI-CDH17 Antibodies And Use Of The SameApplication 63442389Pending
- Ph-selective ANTI-CD3 Antibodies And Use Of The SameApplication 63431611Pending
- Ph-selective ANTI-CD3 Antibodies And Use Of The SameApplication 63346795Pending
- SARS-COV(-2) Spike Glycoprotein-binding Domains And Polypeptides Comprising The Same And Use Of The SameApplication PCTUS2021049724Pending
- SARS-COV(-2) Spike Glycoprotein-binding Domains And Polypeptides Comprising The Same And Use Of The SameApplication 63076885Pending
- Humanized ANTI-CDH17 Antibodies And Use Of The SameApplication PCTUS2025041173Pending
- P- And E-selectin-binding Compositions And Methods Of Use ThereofApplication 19503279Pending
- Humanized ANTI-CDH17 Antibodies And Use Of The SameApplication 63680227Pending
- P- And E-selectin-binding Compositions And Methods Of Use ThereofApplication PCTUS2024038872Pending
Related companies, and why
- ILiAD BiotechnologiesSimilar federal contract value in Biotech · null in contracts
- Acrivon Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Circle Pharma, Inc.Similar federal contract value in Biotech · null in contracts
- Entact Bio, Inc.Similar federal contract value in Biotech · null in contracts
- CIRC Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- HGG RESEARCH, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .